Диссертация (1139499), страница 48

Просмтор этого файла доступен только зарегистрированным пользователям. Но у нас супер быстрая регистрация: достаточно только электронной почты!

Текст из файла (страница 48)

– 1998. – Vol. 54. – P. 926-931.444. Orth SR. Smoking and the kidney/ Orth SR. //J Am Soc Nephrol. – 2002. –Vol.13. – P.1663-72445. Os I. Essential hypertension in women./ Os I. [et al]// Blood press. – 2004. –Vol.13. – P.272-278.297446.

Overlie I. The Endocrine Transition Around Menopause – a Five YearsProspective Study with Profiles of Gonadotropins, Estrogens, Androgens and SHBGAmong Healthy Women./ Overlie I. [et al]// Acta Obstet Gynecol Scand. -1999. –Vol.78. - P.642-7.447. Palatini P. Premenopausal Women Have Increased Risk of Hypertensive TargetOrgan Damage Compared with Men of Similar Age./ Palatini P [et al]// J Women’sHealth. – 2011. – Vol.20(8). – P.1175– 81.448. Palmer B.F.

Impaired renal autoregulation: implications for the genesis ofhypertension and hypertension-induced renal injury/ Palmer B.F. // Am J Med Sci. –2001. – Vol.321. – Р. 388-400.449. Panza JA. Abnormal endothelium-dependent vascular relaxation in patients withessential hypertension./ Panza JA [et al]// N Engl J Med. – 1990. – Vol.323. –P.22–7.450.

Panza JA. Role of endothelium-derived nitric oxide in the abnormal endotheliumdependent vascular relaxation of patients with essential hypertension./ Panza JA [et al]//Circulation. – 1993. – Vol.87. – P.1468–1474.451. Papanek PE. Gender-specific protection from microvessel rarefaction in femalehypertensive rats./ Papanek PE [ et al]// Am J Hypertens. – 1998. – Vol.11. – P.998–1005.452. Paquot N. Adipocytokines: link between obesity, type 2 diabetes andatherosclerosis./ Paquot N, Tappy L. // Rev Med Liege. – 2005. – Vol.60(5-6).

P.369–73.453. Parker WH. Ovarian conservation at the time of hysterectomy and long-termhealth outcomes in the nurses’ health study./ Parker WH [et al]// Obstet Gynecol. –2009. – Vol.113. – P.1027–37.454. Payne JR. Left ventricular growth response to exercise and cigarette smoking:data from LARGE Heart/ Payne J.R. [et al]// Heart. – 2006.

– Vol.92. – P.1784-1788.455. Pechère-Bertschi A, Burnier M. Female sex hormones, salt, and blood pressureregulation./ Pechère-Bertschi A, Burnier M. // Am J Hypertens. – 2004. –Vol.17. –P.994–1001.298456. Pedrinelli R. Microalbuminuria and endothelial dysfunction in essentialhypertension./ Pedrinelli R [et al]// Lancet. – 1994.

– Vol.344. – P.14-8.457. Perk J. European Guidelines on cardiovascular disease prevention in clinicalpractice (version 2012). The Fifth Joint Task Force of the European Society ofCardiology and Other Societies on Cardiovascular Disease Prevention in ClinicalPractice (constituted by representatives of nine societies and by invited experts)./ Perk J.[et al]// Eur Heart J. – 2012. – Vol.33. – P.1635–1701.458. Peters SA. Diabetes as risk factor for incident coronary heart disease in womencompared with men: a systematic review and meta-analysis of 64 cohorts including858,507 individuals and 28,203 coronary events./ Peters SA, Huxley RR, Woodward M.// Diabetologia. – 2014. – Vol.57(8).

– P.1542-51.459. Phillips G.B. The association of hypotestosteronemia with coronary artery diseasein men./ Phillips G.B. [et al] // Arterioscler. Thromb. – 1994. – Vol. 14. - № 5. – P.701–705460. Pierdomenico S.D. Endothelial function in sustained and white coat hypertension/Pierdomenico S.D. [at al.] //Am J Hypertens.

– 2002. – Vol.15(11). – P.946-52.461. Pilote L. A comprehensive view
 of sex-specific issues related to cardiovasculardisease./ Pilote L [et al]// Can Med Assoc J. – 2007. – Vol.176(6). – P.S1-44.462. Pilote L. Incorporating sex and gender in cardiovascular research: the time hascome./ Pilote L., Humphries KH.// Can J Cardiol.

– 2014. – Vol.30. – P.699-702.463. Pines A. Exercise echocardiography in postmenopausal hormone users with mildsystemic hypertension/ Pines A. [et al]// Am J Cardiol. - 1996. - Vol.78. - №12. P.1385-1389.464. Pittilo RM. Nicotine and cigarette smoking.//Effects on the ultrastructure of aorticendothelium./ Pittilo RM [et al]// Int J Exp Pathol.

– 1990. - Vol. 71. – P. 573-586.465. Polderman KH. Influence of sex hormones on plasma endothelin levels./Polderman KH [et al]// Ann Intern Med. – 1993. – Vol.118. – P.429–432.466. Pretorius M. Smoking Impairs Bradykinin-Stimulated t-PA Release/ Pretorius M.[et al]// Hypertension. – 2002. – Vol.39. – P.767-771.299467. Prospective Studies Collaboration. Age-specific Relevance of Usual BloodPressure to Vascular Mortality: a Meta-analysis of Individual Data for One MillionAdults in 61 Prospective Studies.// Lancet. – 2002. – Vol.360.

– P.1903–13.468. Proudler AJ. Hormone replacement therapy and serum angiotensin-convertingenzyme activity in postmenopausal women./ Proudler AJ [et al]// Lancet. – 1995. –Vol.346. – P.89 –90.469. Pyörälä K. Risk factor management in diabetic and non-diabetic patients withcoronary heart disease. Findings from the EUROASPIRE I AND II surveys./ Pyörälä K[et al]// Diabetologia. – 2004. – Vol.47 (7). – P.1257–1265.470. Quehenberger P. Leptin induces endothelin-1 in endothelial cells in vitro./Quehenberger P.

[et al]// Circul Res. – 2002. – Vol.90. – P.711-718.471. Rabelink TJ. Effects of endothelin-1 on renal function in humans: implicationsfor physiology and pathophysiology./ Rabelink TJ [et al]// Kidney Int. – 1994. – Vol.46.– P.376–381.472. Rabi DM. Reporting on sex-based analysis in clinical trials of angiotensinconverting enzyme inhibitor and angiotensin receptor blocker efficacy./ Rabi DM [etal]// Can J Cardiol. – 2008. – Vol.24.

– P.491–496.473. Raij L. Glomerular mesangium: its function and relationship to angiotensin II/Raij L., Keane W. // Am J Med. – 1985. – Vol. 79(Suppl.3C). – P.24-30.474. Raz L. Considerations of sex and gender differences in preclinical and clinicaltrials. In: Regitz-Zagrosek V (ed) Sex and gender differences in pharmacology./ Raz L,Miller VM/ Springer, Heidelberg. – 2012.475. Reckelhoff JF.

Gender differences in hypertension in spontaneously hypertensiverats: role of androgens and androgen receptor./ Reckelhoff JF [et al]// Hypertension. –1999. – Vol.34. – P.920-923.476. Reckelhoff JF. Sex steroids, cardiovascular disease, and hypertension:unanswered questions and some speculations./ Reckelhoff JF// Hypertension.

– 2005. –Vol.45(2). – P.170–174.300477. Regitz-Zagrosek V. Role of gender in heart failure with normal left ventricularejection fraction./ Regitz-Zagrosek V, Brokat S, Tschope C. // Prog Cardiovasc Dis. –2007. – Vol.49 (4). – P.241–251.478. Regitz–Zagrosek V. Gender differences in the metabolic syndrome and their rolefor cardiovascular disease./ Regitz–Zagrosek V, Lehmkuhl E, Weickert MO // Clin ResCardiol. – 2006. – Vol.95(3). – P.136–47.479. Reid R.L. Premenstrual syndrome./ Reid R.L.

// Curr Probl Obstet Gynecol Fertil.– 1985. - Vol. 8. - P. 1.480. Reiner Z. ESC/EAS Guidelines for the management of dyslipidaemias. The TaskForce for the management of dyslipidaemias of the European Society of Cardiology(ESC) and the European Atherosclerosis Society (EAS)./ Reiner Z. [et al]// Eur Heart J.– 2011.

– Vol.32. – P.1769–1818.481. Report of the Public Health Service Task Force on Women’s Health Issues.Women’s Health. Report of the Public Health Service Task Force on Women’s HealthIssues.// Public Health Rep. – 1985. – Vol.100. - P.73-106.482. Reyes D. Gender differences in hypertension and kidney disease/ Reyes D., LewS.Q., Kimmel P.L. // Med Clin North Am.

– 2005. – Vol.89(3). – P. 613-630.483. Rider OJ. Gender-specific differences in left ventricular remodelling in obesity:insights from cardiovascular magnetic resonance imaging./ Rider OJ [et al]// Eur HeartJ. – 2013. – Vol.34(4). – P.292-9.484. Ridker PM. Endogenous tissue-type plasminogen activator and risk of myocardialinfarction./ Ridker PM [et al]// Lancet. – 1993. – Vol.341. – P.1165-8.485. Ritz E.

Effects of smoking on renal hemodynamics in healthy volunteers and inpatients with glomerular disease./ Ritz E. [e tal]// J Am Soc Nephrol. – 1998. – Vol. 9.– P. 1798-1804.486. Rodriguez A. The inhibitory effect of leptin on angiotensin II-inducedvasoconstriction in vascular smooth muscle cells is mediated via a nitricoxidedependent mechanism./ Rodriguez A [et al]// Endocrinology. – 2007. – Vol.148. –P.324–31.301487. Rodriguez-Colon SM. Metabolic syndrome clusters and the risk of incidentstroke: the atherosclerosis risk in communities (ARIC) study./ Rodriguez-Colon SM [etal]// Stroke.

– 2009. – Vol.40(1). – P.200-5.488. Rosano G.M. Effect of estrogen replacement therapy on heart rate variability andheart rate in healthy postmenopausal women./ Rosano G.M. [et al]// Am J Cardiol. –1997. – Vol.80(6). – P.815-17.489. Rosano G.M.C. 17-beta-estradiol therapy lessens angina in postmenopausalwomen with syndrome X./ Rosano G.M.C. [et al]// J Am Coll Cardiol. – 1996. - Vol.28(6).- P.1500–1505.490.

Rosenfeld CR. Estrogen selectively up-regulates enos and nnos in reproductivearteries by transcriptional mechanisms./ Rosenfeld CR [et al]// J Soc Gynecol Investig.– 2003. – Vol.10. – P.205-15.491. Rossi P. Gender differences in artery wall biomechanical properties throughoutlife./ Rossi P. [et al]// J Hyperten. – 2011. – Vol.29(6).

Характеристики

Список файлов диссертации